Oncology PracticeCheckpoint inhibitor seems safe and effective for patients with HIVOctober 23, 2018Immuno-oncologyMelanomaLung Cancer
Oncology PracticePCI safely improves iPFS and OS in advanced NSCLCOctober 23, 2018Lung CancerCNS/Brain Cancer
Oncology PracticeDETERRED trial: Concurrent atezolizumab, CRT shows promise in LA-NSCLCOctober 15, 2018Lung CancerImmuno-oncology
Oncology PracticeALTA-1L: Brigatinib beats crizotinib for PFS in ALK-positive NSCLCOctober 9, 2018Lung CancerB Cell Lymphoma
Oncology PracticeEpacadostat plus pembrolizumab shows promise in advanced solid tumorsOctober 5, 2018Immuno-oncologyMelanomaRenal Cell CarcinomaLung CancerHead & Neck/Thyroid CancersGynecologic Cancer
Oncology PracticeIMPower132 trial: Atezolizumab improves PFS in advanced nonsquamous NSCLCOctober 3, 2018Lung Cancer
Oncology PracticeIMpower133: Atezolizumab plus standard chemotherapy boosted survival in ES-SCLCOctober 2, 2018Lung CancerImmuno-oncology
Oncology PracticeALEX: Alectinib showed superior CNS efficacy in ALK+ NSCLCOctober 1, 2018Lung Cancer
Oncology PracticeFDA approves oral dacomitinib for some metastatic NSCLCSeptember 28, 2018Lung Cancer
Oncology PracticePACIFIC trial: Durvalumab improves both OS and PFS in stage III NSCLCSeptember 28, 2018Immuno-oncologyLung Cancer
Hematology NewsDoes America have a gabapentinoid problem?September 27, 2018Business of MedicineLung Cancer
Oncology PracticeNELSON trial: CT Screening reduces lung cancer deathsSeptember 25, 2018Lung CancerPreventive Care
